EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Community and Hospital‐Based Laboratory Surveillance for Influenza, Respiratory Syncytial Virus, and SARS‐CoV‐2 During the 2023–2024 Season, Lyon, France

Cécile Chauvel iD, Jean-Sébastien Casalegno iD, Benoit Visseaux, Vincent Vieillefond, Stéphanie Haim-Boukozba, Vincent Enouf, Emmanuel Chanard, Margaux Fabre, Marie-Anne Rameix-Welti, Antoine Oblette, Jean-Marc Giannoli, Juliette Paireau und 7 weitere

Journal of Medical Virology · 2025

DOI: 10.1002/jmv.70549 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Virology, 2025. Verfasst von Cécile Chauvel und 18 weiteren Autor:innen. Beteiligte Einrichtung: Center of Excellence in Respiratory Pathogens (CERP), Hospices Civils de Lyon (HCL), Lyon, France. Hauptthemen laut MEDLINE: Respiratory Syncytial Virus Infections, COVID-19, Influenza, Human. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This study received partial support from the CERP..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Influenza, respiratory syncytial virus (RSV) and SARS‐CoV‐2 are among the main respiratory viruses circulating in the population, with a significant burden on public health. While individuals at higher risk are more likely to develop severe symptoms leading to hospitalization, viral circulation in the community remains less extensively monitored. This study compared viral circulation between RELAB, a recently established community‐based laboratory surveillance network ( n = 22 843 tested patients) and hospital surveillance at the Hospices Civils de Lyon, France ( n = 23 046 tested patients), for the season 2023–2024. For influenza and SARS‐CoV‐2, similar trends were observed in at‐risk populations (children under 5 years and adults over 65 years) in both settings. Circulation of these two viruses was first detected in the community and insights from the young adult population (19–64 years) were only captured in the community network. Circulation of RSV was more intense in terms of number of cases and started in the pediatric population, and consequently was more represented in the hospital setting. In conclusion, this study highlighted the complementarity between community and hospital surveillance, as different populations and periods of viral circulation were observed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Respiratory Syncytial Virus InfectionsCOVID-19Influenza, HumanHumansFranceAdultMiddle AgedChildAgedChild, PreschoolYoung AdultSARS-CoV-2MaleFemaleAdolescentInfantSeasonsRespiratory Syncytial Virus, HumanHospitalsEpidemiological MonitoringAged, 80 and over

Stichwörter der Autor:innen

RSVSARS‐CoV‐2communityhospitalinfluenzasurveillance network

Autor:innen und Institutionen

  • Center of Excellence in Respiratory Pathogens (CERP), Hospices Civils de Lyon (HCL), Lyon, France.
  • Centre International de Recherche en Infectiologie (CIRI), Équipe Santé Publique, Épidémiologie et Écologie Évolutive des Maladies Infectieuses (PHE3ID), INSERM U1111, CNRS UMR5308, ENS de Lyon, Université Claude Bernar…
  • Laboratoire de Virologie, Centre National de Référence des Virus des Infections Respiratoires, Institut des Agents Infectieux, Hospices Civils de Lyon, Lyon, France.
  • Laboratoire VirPath, Centre International de Recherche en Infectiologie (CIRI), INSERM U1111, CNRS UMR5308, ENS de Lyon, UCBL, Lyon, France.
  • Laboratoire Cerba, Département d'infectiologie, Cerba Healthcare, Frépillon, France.
  • BPO-BIOEPINE-Biogroup, Levallois-Perret, France.

ORCID-Profile: Cécile Chauvel, Jean-Sébastien Casalegno, Alexandre Gaymard, Marta C Nunes, Antonin Bal

Förderung

  • This study received partial support from the CERP.

Zitieren

APA

Chauvel, C., Casalegno, J. S., Visseaux, B., Vieillefond, V., Haim-Boukozba, S., Enouf, V., Chanard, E., Fabre, M., Rameix-Welti, M. A., Oblette, A., Giannoli, J. M., Paireau, J., Josset, L., Lina, B., Gaymard, A., Cauchemez, S., Morfin, F., Nunes, M. C., & Bal, A. (2025). Community and Hospital‐Based Laboratory Surveillance for Influenza, Respiratory Syncytial Virus, and SARS‐CoV‐2 During the 2023–2024 Season, Lyon, France. Journal of Medical Virology. https://doi.org/10.1002/jmv.70549

Vancouver

Chauvel C, Casalegno JS, Visseaux B, Vieillefond V, Haim-Boukozba S, Enouf V, et al. Community and Hospital‐Based Laboratory Surveillance for Influenza, Respiratory Syncytial Virus, and SARS‐CoV‐2 During the 2023–2024 Season, Lyon, France. Journal of Medical Virology. 2025. doi:10.1002/jmv.70549

BibTeX
@article{Chauvel2025,
  author = {Chauvel, Cécile and Casalegno, Jean-Sébastien and Visseaux, Benoit and Vieillefond, Vincent and Haim-Boukozba, Stéphanie and Enouf, Vincent and Chanard, Emmanuel and Fabre, Margaux and Rameix-Welti, Marie-Anne and Oblette, Antoine and Giannoli, Jean-Marc and Paireau, Juliette and Josset, Laurence and Lina, Bruno and Gaymard, Alexandre and Cauchemez, Simon and Morfin, Florence and Nunes, Marta C and Bal, Antonin},
  title = {Community and Hospital‐Based Laboratory Surveillance for Influenza, Respiratory Syncytial Virus, and SARS‐CoV‐2 During the 2023–2024 Season, Lyon, France},
  journal = {Journal of Medical Virology},
  year = {2025},
  doi = {10.1002/jmv.70549}
}
Kostenlos starten →